Related Experiment Video

Updated: Apr 18, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.1K

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

Jens Y Humrich1, Caroline von Spee-Mayer1, Elise Siegert1

  • 1Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany.

Annals of the Rheumatic Diseases
|January 23, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CytokinesSystemic Lupus ErythematosusT CellsTreatment

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

879

Related Experiment Videos

Last Updated: Apr 18, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.1K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

879

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

738
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
738

Articles linked to this work by shared authors, journal, and citation graph.

Safety and pharmacokinetics of inhaled aloxistatin: A first-in-human phase 1 dose escalation trial.

British journal of clinical pharmacology·2026

Selective ablation of dsDNA-specific plasma cells improves lupus nephritis in NZB/W mice.

Proceedings of the National Academy of Sciences of the United States of America·2026

Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study.

Rheumatology (Oxford, England)·2026

Cytokine-mediated activation of kidney-infiltrating CD8+ T cells enables their contribution to inflammation in human lupus nephritis.

Science translational medicine·2026

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Annals of the rheumatic diseases·2026

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Annals of the rheumatic diseases·2026

Multiomics landscape of systemic sclerosis: from autoantibody-positivity to established disease.

Annals of the rheumatic diseases·2026

IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort.

Annals of the rheumatic diseases·2026

Early arthritis signs and symptoms revisited-is synovitis what we are assessing?

Annals of the rheumatic diseases·2026

Preclinical and clinical outcomes in patients with high rheumatoid factor levels treated with TNF inhibitors:a systematic review.

Annals of the rheumatic diseases·2026

Immune reset in rheumatic autoimmune disease: from a tantalising metaphor to a measurable therapeutic state.

Annals of the rheumatic diseases·2026

DNA methylation signatures distinguish gout from asymptomatic hyperuricaemia and converge with genetic risk at immune-metabolic loci.

Annals of the rheumatic diseases·2026

Case Report: Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B-Cell Depletion Therapy to Ravulizumab.

Clinical case reports·2026

Eculizumab in rapidly progressive glomerulonephritis: a case-series report.

Frontiers in immunology·2026

Flurbiprofen for Inflammatory Bowel Disease: A Review of Colon-Targeted Formulations.

Recent advances in drug delivery and formulation·2026

Optimal Transfusion Thresholds in Patients with Acute Brain Injury: A Bayesian Network Meta-analysis of Randomized Controlled Trials.

Neurocritical care·2026

Heart-specific T cell responses: from antigens to disease mechanisms.

Nature reviews. Cardiology·2026

Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.

Critical reviews in oncology/hematology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us